{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:47:20Z","timestamp":1790081240076,"version":"4.0.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ophtha.2025.07.015","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T23:12:38Z","timestamp":1753398758000},"page":"1335-1341","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Corneal Staining Responder Analysis"],"prefix":"10.1016","volume":"132","author":[{"given":"Esen K.","family":"Akpek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1216-4056","authenticated-orcid":false,"given":"John D.","family":"Sheppard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2049-2076","authenticated-orcid":false,"given":"Sonja","family":"Kr\u00f6sser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.ophtha.2025.07.015_bib1","doi-asserted-by":"crossref","first-page":"9271","DOI":"10.3390\/ijms21239271","article-title":"Defining dry eye from a clinical perspective","volume":"21","author":"Tsubota","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.ophtha.2025.07.015_bib2","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","article-title":"TFOS DEWS II Diagnostic Methodology report","volume":"15","author":"Wolffsohn","year":"2017","journal-title":"Ocul Surf"},{"issue":"8","key":"10.1016\/j.ophtha.2025.07.015_bib3","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/01.ico.0000133997.07144.9e","article-title":"The lack of association between signs and symptoms in patients with dry eye disease","volume":"23","author":"Nichols","year":"2004","journal-title":"Cornea"},{"issue":"9","key":"10.1016\/j.ophtha.2025.07.015_bib4","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.2147\/OPTH.S89700","article-title":"Associations between signs and symptoms of dry eye disease: a systematic review","volume":"16","author":"Bartlett","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.07.015_bib5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ajo.2023.09.024","article-title":"United States regulatory approval of topical treatments for dry eye","volume":"258","author":"Cui","year":"2024","journal-title":"Am J Ophthalmol"},{"issue":"11S","key":"10.1016\/j.ophtha.2025.07.015_bib7","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.ophtha.2017.07.010","article-title":"The pathophysiology of dry eye disease: what we know and future directions for research","volume":"124","author":"Pflugfelder","year":"2017","journal-title":"Ophthalmology"},{"issue":"13","key":"10.1016\/j.ophtha.2025.07.015_bib8","doi-asserted-by":"crossref","first-page":"9516","DOI":"10.1167\/iovs.11-8412","article-title":"Corneal fluorescein staining correlates with visual function in dry eye patients","volume":"52","author":"Kaido","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.ophtha.2025.07.015_bib9","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1167\/iovs.17-21894","article-title":"The effect of ocular surface regularity on contrast sensitivity and straylight in dry eye","volume":"58","author":"Koh","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"Suppl 1","key":"10.1016\/j.ophtha.2025.07.015_bib10","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1097\/ICO.0000000000000998","article-title":"Mechanisms of visual disturbance in dry eye","volume":"35","author":"Koh","year":"2016","journal-title":"Cornea"},{"issue":"12","key":"10.1016\/j.ophtha.2025.07.015_bib11","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1136\/bjophthalmol-2018-312333","article-title":"Effects of tear film dynamics on quality of vision","volume":"102","author":"Koh","year":"2018","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ophtha.2025.07.015_bib12","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1080\/09273948.2022.2027461","article-title":"Outcome measures to assess dry eye severity: a review","volume":"30","author":"Hirabayashi","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"10.1016\/j.ophtha.2025.07.015_bib13","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/bjophthalmol-2015-308237","article-title":"Functional impairment of reading in patients with dry eye","volume":"101","author":"Mathews","year":"2017","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"10.1016\/j.ophtha.2025.07.015_bib14","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.ophtha.2018.03.039","article-title":"Effects of prolonged reading on dry eye","volume":"125","author":"Karakus","year":"2018","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ophtha.2025.07.015_bib15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/OPX.0b013e3182780dbb","article-title":"Evaluation of reading speed and contrast sensitivity in dry eye disease","volume":"90","author":"Ridder","year":"2013","journal-title":"Optom Vis Sci"},{"issue":"3","key":"10.1016\/j.ophtha.2025.07.015_bib16","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1177\/11206721221141481","article-title":"panel of European dry eye disease experts. Management of inflammation in dry eye disease: recommendations from a European panel of experts","volume":"33","author":"Messmer","year":"2023","journal-title":"Eur J Ophthalmol"},{"issue":"9","key":"10.1016\/j.ophtha.2025.07.015_bib17","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/ICO.0000000000002622","article-title":"SEECASE study group. A Randomized Clinical Study (SEECASE) to assess efficacy, safety, and tolerability of NOV03 for treatment of dry eye disease","volume":"40","author":"Tauber","year":"2021","journal-title":"Cornea"},{"issue":"10","key":"10.1016\/j.ophtha.2025.07.015_bib18","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1097\/ICO.0000000000002633","article-title":"A water-free 0.1% cyclosporine A solution for treatment of dry eye disease: results of the randomized phase 2B\/3 ESSENCE Study","volume":"40","author":"Sheppard","year":"2021","journal-title":"Cornea"},{"issue":"5","key":"10.1016\/j.ophtha.2025.07.015_bib19","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1001\/jamaophthalmol.2023.0709","article-title":"Efficacy and safety of a water-free topical cyclosporine, 0.1%, solution for the treatment of moderate to severe dry eye disease: The ESSENCE-2 Randomized Clinical Trial","volume":"141","author":"Akpek","year":"2023","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"10.1016\/j.ophtha.2025.07.015_bib20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/jamaophthalmol.2024.0101","article-title":"Water-free cyclosporine ophthalmic solution vs vehicle for dry eye disease: a randomized clinical trial","volume":"142","author":"Peng","year":"2024","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"10.1016\/j.ophtha.2025.07.015_bib21","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jtos.2019.01.004","article-title":"Review and analysis of grading scales for ocular surface staining","volume":"17","author":"Begley","year":"2019","journal-title":"Ocul Surf"},{"issue":"6","key":"10.1016\/j.ophtha.2025.07.015_bib22","doi-asserted-by":"crossref","first-page":"BIO168","DOI":"10.1167\/iovs.17-21831","article-title":"Evaluating corneal fluorescein staining using a novel automated method","volume":"58","author":"Amparo","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2025.07.015_bib23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1745-6215-8-31","article-title":"Responder analyses and the assessment of a clinically relevant treatment effect","volume":"8","author":"Snapinn","year":"2007","journal-title":"Trials"},{"issue":"11","key":"10.1016\/j.ophtha.2025.07.015_bib24","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1001\/jamaophthalmol.2021.3943","article-title":"Efficacy of lifitegrast ophthalmic solution, 5.0%, in patients with moderate to severe dry eye disease: a post hoc analysis of 2 randomized clinical trials","volume":"139","author":"Holland","year":"2021","journal-title":"JAMA Ophthalmol"},{"issue":"5","key":"10.1016\/j.ophtha.2025.07.015_bib25","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ophtha.2022.12.021","article-title":"NOV03 for dry eye disease associated with meibomian gland dysfunction: results of the randomized phase 3 GOBI Study","volume":"130","author":"Tauber","year":"2023","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.ophtha.2025.07.015_bib26","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/ICO.0000000000003411","article-title":"Cornea Classic: Bron, Evans, and Smith, \u201cGrading of Corneal and Conjunctival Staining in the Context of Other Dry Eye Tests,\u201d 2003","volume":"43","author":"Akpek","year":"2024","journal-title":"Cornea"},{"issue":"11","key":"10.1016\/j.ophtha.2025.07.015_bib29","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1001\/jamaophthalmol.2021.3943","article-title":"Efficacy of Lifitegrast ophthalmic solution, 5.0%, in patients with moderate to severe dry eye disease: a post hoc analysis of 2 randomized clinical trials","volume":"139","author":"Holland","year":"2021","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.07.015_bib30","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.2147\/OPTH.S392315","article-title":"Effect of OTX-101 in patients with dry eye disease at day 14 of treatment: ocular surface endpoint results from the phase 2b\/3 clinical trial","volume":"16","author":"Schechter","year":"2022","journal-title":"Clin Ophthalmol"},{"issue":"12","key":"10.1016\/j.ophtha.2025.07.015_bib31","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1016\/j.ophtha.2015.08.001","article-title":"Lifitegrast ophthalmic solution 5.0% versus placebo for treatment of dry eye disease: results of the randomized phase III OPUS-2 Study","volume":"122","author":"Tauber","year":"2015","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.ophtha.2025.07.015_bib32","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1167\/iovs.11-8284","article-title":"Standardized assessment of reading performance: the New International Reading Speed Texts IReST","volume":"53","author":"Trauzettel-Klosinski","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.ophtha.2025.07.015_bib33","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1097\/ICO.0000000000000490","article-title":"Optimizing reading tests for dry eye disease","volume":"34","author":"Ousler","year":"2015","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.ophtha.2025.07.015_bib34","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S1542-0124(12)70290-2","article-title":"Corneal pain without stain: is it real?","volume":"7","author":"Rosenthal","year":"2009","journal-title":"Ocul Surf"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016164202500449X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016164202500449X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T12:29:05Z","timestamp":1771417745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016164202500449X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S016164202500449X"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2025.07.015","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Corneal Staining Responder Analysis","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2025.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Ophthalmology.","name":"copyright","label":"Copyright"}]}}